How does CTV advertising work for pharma?

Overview

Connected TV (CTV) advertising represents a transformative shift in pharmaceutical marketing, emerging as streaming services gained mainstream adoption in the late 2010s. Unlike traditional linear TV, CTV refers to internet-connected television devices like smart TVs, streaming sticks (Roku, Amazon Fire TV), and gaming consoles that deliver content through apps. For pharmaceutical companies, this technology arrived at a critical moment when digital health engagement was accelerating, particularly during the COVID-19 pandemic when telehealth adoption surged by 154% in 2020. The pharmaceutical industry's embrace of CTV began gaining significant momentum around 2021, as companies recognized the medium's ability to reach patients who were increasingly cutting traditional cable cords. By 2022, CTV had become an established channel in pharma marketing budgets, with particular growth in therapeutic areas like diabetes, oncology, and autoimmune diseases where patient education is crucial. The regulatory landscape for pharma CTV advertising is governed by FDA guidelines that require fair balance and risk information, creating unique creative challenges compared to other CTV advertising categories.

How It Works

Pharma CTV advertising operates through a sophisticated ecosystem that begins with data integration. Pharmaceutical companies work with specialized healthcare marketing agencies that leverage anonymized patient data, often from health data platforms like IQVIA or Komodo Health, to build audience segments based on diagnosis codes, prescription histories, and health interests. These segments are then matched against CTV platform user data through privacy-compliant methods like hashed email matching or contextual targeting. When a viewer streams content on platforms like Hulu, Paramount+, or Peacock, the CTV platform's ad server selects relevant pharma ads based on the viewer's profile and the content being watched. The ads themselves must include required safety information, which pharma companies typically present through a superimposed text overlay or a companion banner that appears during the ad. Advanced CTV platforms enable sequential messaging, where a viewer might see an awareness-building ad first, followed by more detailed educational content in subsequent exposures. Measurement occurs through multi-touch attribution models that track ad exposure to eventual actions like website visits, telehealth consultations, or prescription requests, often using deterministic matching when viewers log into streaming services.

Why It Matters

CTV advertising matters for pharmaceutical companies because it addresses critical challenges in patient education and brand awareness at scale. With traditional TV viewership declining and digital ad blockers affecting online display campaigns, CTV offers an engaged, measurable channel to reach patients during their leisure time. For patients with chronic conditions, CTV ads can provide timely information about new treatment options and encourage conversations with healthcare providers, potentially improving health outcomes. The medium's targeting precision reduces wasted ad spend compared to broad-reach TV campaigns, while its brand-safe environment addresses pharma companies' compliance concerns. From a business perspective, CTV drives measurable prescription lift—studies show pharma CTV campaigns can increase new prescription starts by 8-12%—making it a valuable component of launch strategies for new medications. As healthcare continues shifting toward patient empowerment and digital engagement, CTV represents a bridge between mass-reach television and personalized digital marketing that can educate patients while driving business results for pharmaceutical companies.